Bioceltix S.A.
BCX | WAR
Overview
Corporate Details
- ISIN(s):
- PLBCLTX00019 (+1 more)
- LEI:
- 259400QZD5JYK8SLZU51
- Country:
- Poland
- Address:
- Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław
- Website:
- https://bioceltix.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Bioceltix is a team of experts working on innovative therapies for veterinary use. We work on biopharmaceuticals that harness the immunomodulatory properties of mesenchymal stem cells. We develop them following the highest quality and safety standards. We possess cutting-edge research and production facilities, cooperate with ambitious scientists, and operate under a well-developed business model. Our goal is to market new, effective solutions in the field of veterinary medicine. The safety and efficacy of Bioceltix products will also be verified through field clinical trials carried out in accordance with Good Clinical Practice (GCP). The independent trials will be conducted in leading veterinary centres, under the supervision of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-05-07 18:29 |
Declaration of Voting Results & Voting Rights Announcements
Informacja o liczbie akcji i głosów
|
Polish | 74.3 KB | |
| 2024-05-07 18:29 |
Governance Information
Klauzula informacyjna o przetwarzaniu danych osobowych
|
Polish | 174.2 KB | |
| 2024-05-07 18:29 |
Proxy Solicitation & Information Statement
Formularz głosowania przez pełnomocnika
|
Polish | 160.9 KB | |
| 2024-05-07 18:29 |
Proxy Solicitation & Information Statement
Formularze pełnomocnictwa
|
Polish | 115.1 KB | |
| 2024-05-07 18:29 |
Registration Form
Zestawienie zmian statutu
|
Polish | 86.8 KB | |
| 2024-05-07 18:29 |
Share Issue/Capital Change
Opinia Zarządu
|
Polish | 73.1 KB | |
| 2024-05-07 18:29 |
Post-Annual General Meeting Information
Projekty uchwał wraz z uzasadnieniem
|
Polish | 148.9 KB | |
| 2024-05-07 18:29 |
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu NWZ
|
Polish | 145.2 KB | |
| 2024-05-07 18:29 |
Pre-Annual General Meeting Information
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
|
Polish | 2.1 KB | |
| 2024-05-07 17:38 |
Share Issue/Capital Change
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
|
Polish | 5.4 KB | |
| 2024-04-26 17:12 |
Annual / Quarterly Financial Statement
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
|
Polish | 10.3 KB | |
| 2024-04-26 17:12 |
Annual / Quarterly Financial Statement
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
|
Polish | 2.9 MB | |
| 2024-04-26 17:12 |
Annual / Quarterly Financial Statement
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
|
Polish | 20.9 KB | |
| 2024-04-26 17:12 |
Annual Report
Raport okresowy roczny Bioceltix S.A. za rok 2023
|
Polish | 17.3 MB | |
| 2024-04-26 17:12 |
Annual Report
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
|
Polish | 20.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |